IRONWOOD PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-116.9M | $-81.7M | $-142.7M | $-189.6M | $-272.8M | $-72.6M | $-64.9M | $-51.9M |
| Depreciation & Amortization | $6.4M | $10.3M | $11.6M | $12.3M | $11.7M | $11.3M | $10.0M | $6.2M |
| Depreciation | $6.4M | — | — | — | — | — | — | — |
| Amortization | $6.2M | $981.0K | — | — | — | — | — | — |
| Stock-Based Compensation | $30.9M | $29.2M | $25.5M | $26.2M | $19.8M | $17.6M | $11.7M | $7.5M |
| Net Cash from Operating Activities | $-100.8M | $-25.9M | $-106.9M | $-155.6M | $-273.4M | $-69.6M | $-75.2M | $-67.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.8M | $4.2M | $4.0M | $3.5M | $9.6M | $14.0M | $9.7M | $17.2M |
| Business Acquisitions | — | $100.0M | — | — | — | — | — | — |
| Net Cash from Investing Activities | $151.5M | $-177.7M | $-9.2M | $-56.6M | $-101.4M | $30.1M | $115.1M | $-213.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $19.8M | $-4.2M | $303.1M | $210.9M | $313.6M | $89.0M | $3.1M | $203.0M |
| Net Change in Cash | $71.7M | $-207.3M | $187.0M | — | — | — | $43.0M | $-78.0M |
| Free Cash Flow | $-103.6M | $-30.1M | $-111.0M | $-159.1M | $-282.9M | $-83.6M | $-84.9M | $-85.1M |